4CPS-024 Effectiveness of anti-interleukin-17 drugs in psoriasis in clinical practice

Autor: N Rudi Sola, D Ferrandez Marti, S Mendiola Garcia, V Charques Trallero, C Seguí Solanes, A Retamero Delgado

Publikováno v: Section 4: Clinical Pharmacy Services.

Background and importance Anti-interleukin-17 (IL-17) drugs are a new option for treating patients with psoriasis which have demonstrated high efficacy in clinical trials. Aim and objectives To analyse the effectiveness of anti-IL-17 drugs for psoria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4f71a7b0a9a6a6a3f285d440132fb39e
https://doi.org/10.1136/ejhpharm-2020-eahpconf.125

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

5PSQ-063 More risk of neutropaenia in obese patients treated with paclitaxel?

Autor: N Almendros-Abad, L Borràs Trias, R Rodriguez Mauriz, C Seguí Solanes, N Rudi Sola, MA Pérez-Quirós, MA Aldirra-Taha, A Planas-Giner

Publikováno v: Section 5: Patient Safety and Quality Assurance.

Background Neutropaenia is one of the most common adverse effects of paclitaxel. It is dose-dependent and has dose-limiting toxicity. However, the American Society of Clinical Oncology (ASCO) guideline recommends the use of real bodyweight for chemot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::321ee677c1a249665c12c9259c30db2d
https://doi.org/10.1136/ejhpharm-2019-eahpconf.496

CP-033 Monitoring off-label use of rilpivirine in a University Hospital

Autor: X Bonafont Pujol, L Vilaró Jaques, G Cardona Peitx, A Andreu Crespo, C Seguí Solanes

Publikováno v: European Journal of Hospital Pharmacy. 21:A13.2-A13

Background Rilpivirine (RPV) is a new non-nucleoside reverse transcriptase inhibitor (NNRTI) approved only in treatment-naive patients although it is commonly used in switch strategy due to its efficacy, lack of side effects and cost. Purpose To desc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7a976967f7949626488806c1c4c36cdd
https://doi.org/10.1136/ejhpharm-2013-000436.32

[Translated article] Knowledge of biological therapy in patients with immune-mediated diseases. BIOINFO study.

Autor: Seguí-Solanes C; Servicio de Farmacia, Hospital de Granollers, Granollers, Barcelona, Spain., Estrada L; Servicio de Farmacia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain., Herráiz ER; Servicio de Farmacia, Hospital Universitario La Princesa, Madrid, Spain. Electronic address: eramirezh@salud.madrid.org., Ruiz-García S; Servicio de Farmacia, Hospital Universitario La Princesa, Madrid, Spain., Palanques-Pastor T; Servicio de Farmacia, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Bohórquez VM; Servicio de Farmacia, Hospital Universitario Virgen de la Macarena, Sevilla, Spain., Montes CC; Servicio de Farmacia, Hospital Universitario del Sureste, Madrid, Spain., Borras-Blasco J; Servicio de Farmacia, Hospital de Sagunto, Sagunto. Valencia, Spain.

Publikováno v: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Sep 23. Date of Electronic Publication: 2024 Sep 23.